Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Genetic Markers for Focal Segmental Glomerulosclerosis

View source ↗

Summary

This clinical trial update reports on genetic markers linked to focal segmental glomerulosclerosis, including HIV-associated forms. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Focal Segmental Glomerulosclerosis, HIV-Associated Focal Segmental Glomerulosclerosis | Status: COMPLETED